EOM Pharmaceuticals Holdings, Inc.

IMUC · OTC
Analyze with AI
12/31/2022
9/30/2022
6/30/2022
3/31/2022
Operating Activities
Net Income-$465-$1-$1
Dep. & Amort.$0$0$0
Deferred Tax$0$0$0
Stock-Based Comp.$0$0$0
Change in WC$93$0$0
Other Non-Cash-$317$1$0
Operating Cash Flow-$688$0-$1
Investing Activities
PP&E Inv.$0$0$0
Net Acquisitions$0$0$0
Inv. Purchases$0$0$0
Inv. Sales/Matur.$0$0$0
Other Inv. Act.$0$0$0
Investing Cash Flow$0$0$0
Financing Activities
Debt Repay.$0$0$0
Stock Issued$0$0$0
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$750$0$0
Financing Cash Flow$750$0$0
Forex Effect$0$0$0
Net Chg. in Cash$62$0-$1
Supplemental Information
Beg. Cash$551$0$1
End Cash$613$0$1
Free Cash Flow-$688$0-$1
EOM Pharmaceuticals Holdings, Inc. (IMUC) Financial Statements & Key Stats | AlphaPilot